2018, Number 4
<< Back Next >>
Ortho-tips 2018; 14 (4)
Meniscus repair and replacement
Muñoz GRA, Pérez MA
Language: Spanish
References: 21
Page: 181-188
PDF size: 168.06 Kb.
ABSTRACT
The clinical association between osteoarthritis and meniscectomy has been shown to be a 1400% risk at 21 years of meniscectomy. The specific characteristics of the tear and the patient are paramount for clinical decision making regarding meniscus repair. The repair of the meniscus is done to restore the native biomechanical properties of its architecture and, in doing so, recreate the circumferential tensions. The biological augmentation strategies try to overcome the inherent limitations of healing related to deficient vascularization and heterogeneous cellularity when promoting chemotaxis, cell proliferation and matrix production at the repair site. In terms of cell-based therapy, the use of differentiated cells and undifferentiated mesenchymal stem cells (CTM) in meniscal repair has been promising. Although not available for use in Mexico, there are two meniscal substitutes available for clinical use, collagen meniscus implant (CMI) and ActiFit
®, which have shown good results in the short and medium term.
REFERENCES
Fairbank TJ. Knee joint changes after meniscectomy. J Bone Joint Surg Br. 1948; 30-B (4): 664-670.
Roos H, Lauren M, Adalberth T, Roos EM, Jonsson K, Lohmander LS. Knee osteoarthritis after meniscectomy: prevalence of radiographic changes after twenty-one years, compared with matched controls. Arthritis Rheum. 1998; 41 (4): 687-693.
Maak TG, Fabricant PD, Wickiewicz TL. Indications for meniscus repair. Clin Sports Med. 2012; 31 (1): 1-14.
Bin SI, Kim JM, Shin SJ. Radial tears of the posterior horn of the medial meniscus. Arthroscopy. 2004; 20: 373-378.
Feucht MJ, Kühle J, Bode G, et al. Arthroscopic transtibial pullout repair for posterior medial meniscus root tears: a systematic review of clinical, radiographic, and second-look arthroscopic results. Arthroscopy. 2015; 31: 1808-1816.
Robertson DD, Armfield DR, Towers JD, et al. Meniscal root injury and spontaneous osteonecrosis of the knee: an observation. J Bone Joint Surg [Br]. 2009; 91: 190-195.
Anderson A. The ISAKOS classification of meniscal tears. ISAKOS NEWELETTER. Winter 2010. 11-13.
He W, Liu YJ, Wang ZG, Guo ZK, Wang MX, Wang N. Enhancement of meniscal repair in the avascular zone using connective tissue growth factor in a rabbit model. Chin M J. 2011; 124 (23): 3968-3975.
Kopf S, Birkenfeld F, Becker R, et al. Local treatment of meniscal lesions with vascular endothelial growth factor. J Bone Joint Surg Am. 2010; 92 (16): 2682-2691.
Narita A, Takahara M, Sato D, et al. Biodegradable gelatin hydrogels incorporating fibroblast growth factor 2 promote healing of horizontal tears in rabbit meniscus. Arthroscopy. 2012; 28 (2): 255-263.
Zaffagnini S, Marcheggiani-Muccioli GM, Bulgheroni P, et al. Arthroscopic collagen meniscus implantation for partial lateral meniscal defects: a 2-year minimum follow-up study. Am J Sports Med. 2012; 40: 2281-2288.
Moriguchi Y, Tateishi K, Ando W, et al. Repair of meniscal lesions using a scaffold-free tissue-engineered construct derived from allogenic synovial MSCs in a miniature swine model. Biomaterials. 2013; 34 (9): 2185-2193.
Ishida K, Kuroda R, Miwa M, et al. The regenerative effects of plateletrich plasma on meniscal cells in vitro and its in vivo application with biodegradable gelatin hydrogel. Tissue Eng. 2007; 13 (5): 1103-1112.
Kaminski R, Kulinski K, Kozar-Kaminska K, et al. A prospective, randomized, double-blind, parallel-group, placebo-controlled study evaluating meniscal healing, clinical outcomes, and safety in patients undergoing meniscal repair of unstable, complete vertical meniscal tears (bucket handle) augmented with platelet-rich plasma. Biomed Res Int. 2018; 2018: 9315815.
Reguzzoni M, Manelli A, Ronga M, Raspanti M, Grassi FA. Histology and ultrastructure of a tissue-engineered collagen meniscus before and after implantation. J Biomed Mater Res B Appl Biomater. 2005; 74 (2): 808-816.
Steadman JR, Rodkey WG. Tissue-engineered collagen meniscus implants: 5- to 6-year feasibility study results. Arthroscopy. 2005; 21 (5): 515-525.
Monllau JC, Gelber PE, Abat F, et al. Outcome after partial medial meniscus substitution with the collagen meniscal implant at a mínimum of 10 years’ follow-up. Arthroscopy. 2011; 27 (7): 933-943.
Zaffagnini S, Marcheggiani-Muccioli GM, Lopomo N, et al. Prospective long-term outcomes of the medial collagen meniscus implant versus partial medial meniscectomy: a minimum 10-year follow-up study. Am J Sports Med. 2011; 39 (5): 977-985.
Verdonk P, Beaufils P, Bellemans J, et al. Successful treatment of painful irreparable partial meniscal defects with a polyurethane scaffold: two-year safety and clinical outcomes. Am J Sports Med. 2012; 40: 844-853.
Verdonk R, Verdonk P, Huysse W, Forsyth R, Heinrichs EL. Tissue in growth after implantation of a novel, biodegradable polyurethane scaffold for treatment of partial meniscal lesions. Am J Sports Med. 2011; 39 (4): 774-782.
Monllau JC, Poggioli F, Erquicia J, et al. Magnetic resonance imaging and functional outcomes after a polyurethane meniscal scaffold implantation: Minimum 5-years follow-up. Arthroscopy. 2018; 34: 1621-1627.